Stock listing
NASDAQ:LEXX Lexaria Bioscience Corp. Stock
Home listing (NASDAQ) of Lexaria Bioscience Corp.
Follow Lexaria Bioscience Corp. into a list and get an email when it puts out news.
Share price · NASDAQ:LEXX
$4.03 USD -0.25 (-5.8%)
Close on Nov 20, 2026
- Day range
- $4.03 – $4.51 USDNov 20, 2026
- Volume
- 32,861 sharesNov 20, 2026
- Market cap
- $8.49M USDAt the close on Nov 20, 2026 · price × 2.11M shares outstanding
- 52-week range
- $2.43 – $21.60 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $409,341 USDMedian day 38,984 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:LEXX · Home | $4.03 USD | -0.25 (-5.8%) | 32,861 | $4.51 | $4.51 | $4.03 | $4.28 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:LEXX · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $4.03 | -0.25 | -5.8% | $4.51 | $4.51 | $4.03 | 32,861 | |
| $4.28 | +0.10 | +2.4% | $4.03 | $4.49 | $4.03 | 13,238 | |
| $4.18 | -0.23 | -5.2% | $4.13 | $4.41 | $3.96 | 37,271 | |
| $4.41 | -0.03 | -0.7% | $4.445 | $4.46 | $4.00 | 14,989 | |
| $4.44 | +0.26 | +6.2% | $4.32 | $4.44 | $4.19 | 9,012 | |
| $4.18 | -0.46 | -9.9% | $4.02 | $4.44 | $4.02 | 34,048 | |
| $4.64 | -0.04 | -0.9% | $4.65 | $4.78 | $4.455 | 9,014 | |
| $4.68 | +0.14 | +3.1% | $4.50 | $4.79 | $4.50 | 11,013 | |
| $4.54 | +0.04 | +0.9% | $4.63 | $4.69 | $4.41 | 17,929 | |
| $4.50 | +0.33 | +7.9% | $4.098 | $4.71 | $4.098 | 29,449 | |
| $4.17 | +0.10 | +2.5% | $4.07 | $4.19 | $3.87 | 29,759 | |
| $4.07 | +0.04 | +1.0% | $4.01 | $4.30 | $3.875 | 32,134 | |
| $4.03 | +0.39 | +10.7% | $3.79 | $4.10 | $3.70 | 32,023 | |
| $3.64 | +0.15 | +4.3% | $3.50 | $3.96 | $3.445 | 23,920 | |
| $3.49 | -0.28 | -7.4% | $3.63 | $3.63 | $3.21 | 37,694 | |
| $3.77 | +0.47 | +14.2% | $3.38 | $3.87 | $3.30 | 38,984 | |
| $3.30 | +0.08 | +2.5% | $3.18 | $3.55 | $3.065 | 38,919 | |
| $3.22 | +0.30 | +10.3% | $3.10 | $3.31 | $2.96 | 41,763 | |
| $2.92 | -0.16 | -5.2% | $3.08 | $3.08 | $2.83 | 13,831 | |
| $3.08 | +0.09 | +3.0% | $2.98 | $3.199 | $2.84 | 23,200 | |
| $2.99 | +0.17 | +6.0% | $2.74 | $3.00 | $2.51 | 16,500 | |
| $2.82 | +0.17 | +6.4% | $2.68 | $2.89 | $2.516 | 28,700 | |
| $2.65 | +0.05 | +1.9% | $2.60 | $2.68 | $2.46 | 41,900 | |
| $2.60 | -0.26 | -9.1% | $2.79 | $2.85 | $2.43 | 44,600 | |
| $2.86 | -0.13 | -4.3% | $3.19 | $3.24 | $2.81 | 123,900 | |
| $2.99 | +0.17 | +6.0% | $2.74 | $3.11 | $2.74 | 37,200 | |
| $2.82 | +0.02 | +0.7% | $2.81 | $2.92 | $2.43 | 103,900 | |
| $2.80 | -0.47 | -14.4% | $3.29 | $3.29 | $2.69 | 117,900 | |
| $3.27 | -0.05 | -1.5% | $3.18 | $3.624 | $3.18 | 66,100 | |
| $3.32 | +0.12 | +3.7% | $3.31 | $3.90 | $3.12 | 198,400 | |
| $3.20 | -0.26 | -7.5% | $3.50 | $3.669 | $3.19 | 26,500 | |
| $3.46 | +0.22 | +6.8% | $3.14 | $3.59 | $3.10 | 76,900 | |
| $3.24 | +0.47 | +17.0% | $2.925 | $3.24 | $2.86 | 66,100 | |
| $2.77 | -0.11 | -3.8% | $2.90 | $3.125 | $2.77 | 38,700 | |
| $2.88 | -0.21 | -6.8% | $3.18 | $3.24 | $2.80 | 80,100 | |
| $3.09 | -0.06 | -1.9% | $3.20 | $3.25 | $2.95 | 48,700 | |
| $3.15 | +0.02 | +0.6% | $3.21 | $3.29 | $3.06 | 23,100 | |
| $3.13 | -0.095 | -2.9% | $3.28 | $3.34 | $2.98 | 77,500 | |
| $3.225 | -0.055 | -1.7% | $3.25 | $3.46 | $3.15 | 41,900 | |
| $3.28 | -0.09 | -2.7% | $3.455 | $3.455 | $3.15 | 34,200 | |
| $3.37 | +0.135 | +4.2% | $3.29 | $3.595 | $3.142 | 51,800 | |
| $3.235 | +0.015 | +0.5% | $3.31 | $3.34 | $3.10 | 14,400 | |
| $3.22 | -0.205 | -6.0% | $3.54 | $3.84 | $3.08 | 107,300 | |
| $3.425 | +0.185 | +5.7% | $3.29 | $3.48 | $3.15 | 26,000 | |
| $3.24 | -0.05 | -1.5% | $3.25 | $3.52 | $3.15 | 76,300 | |
| $3.29 | +0.195 | +6.3% | $3.07 | $4.00 | $2.91 | 161,400 | |
| $3.095 | -0.115 | -3.6% | $3.28 | $3.47 | $2.80 | 150,400 | |
| $3.21 | -0.34 | -9.6% | $3.54 | $3.932 | $2.98 | 123,700 | |
| $3.55 | -0.42 | -10.6% | $3.98 | $4.15 | $3.14 | 178,900 | |
| $3.97 | -0.08 | -2.0% | $4.15 | $4.72 | $3.645 | 195,900 | |
| $4.05 | -2.55 | -38.6% | $7.00 | $7.50 | $4.04 | 223,500 | |
| $6.60 | -2.77 | -29.6% | $9.44 | $9.52 | $6.405 | 74,300 | |
| $9.37 | -4.78 | -33.8% | $11.09 | $11.09 | $8.81 | 121,200 | |
| $14.15 | +1.83 | +14.9% | $12.26 | $14.37 | $12.26 | 22,400 | |
| $12.32 | -0.885 | -6.7% | $13.33 | $13.93 | $12.25 | 74,700 | |
| $13.21 | +0.73 | +5.9% | $12.63 | $13.61 | $12.40 | 40,900 | |
| $12.48 | +1.195 | +10.6% | $11.13 | $12.89 | $11.13 | 65,400 | |
| $11.28 | +0.93 | +9.0% | $10.30 | $12.20 | $10.30 | 359,500 | |
| $10.35 | -1.33 | -11.4% | $11.42 | $12.48 | $10.35 | 61,900 | |
| $11.68 | +0.64 | +5.8% | $10.97 | $11.78 | $10.24 | 505,600 | |
| $11.04 | -0.56 | -4.8% | $11.70 | $11.90 | $11.00 | 5,200 | |
| $11.60 | +1.06 | +10.1% | $10.75 | $11.60 | $10.60 | 12,300 | |
| $10.54 | -0.375 | -3.4% | $10.96 | $11.10 | $10.41 | 14,900 | |
| $10.92 | -0.355 | -3.1% | $11.38 | $11.53 | $10.80 | 8,900 | |
| $11.27 | -0.24 | -2.1% | $11.96 | $12.89 | $11.24 | 67,100 |
Splits
1 split · NASDAQ:LEXX · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-15 | Consolidation |
- Ticker
- NASDAQ:LEXX
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
What changed lately
Latest news release · Nov 19, 2026
Lexaria's Human Study GLP-1-H26-7 Completes Dosing as Scheduled
Latest news
Lexaria's Human Study GLP-1-H26-7 Completes Dosing as Scheduled
Nov 19, 2026
Closed $4.03 (-5.8%) on Nov 20, 2026
Lexaria Enters a New Pharmaceutical Agreement for DehydraTECH
Nov 4, 2026
Closed $4.07 (+1.0%) on Nov 4, 2026
Lexaria Celebrates its 70th Patent Award
Oct 28, 2026
Closed $3.30 (+2.5%) on Oct 28, 2026
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
Oct 21, 2026
Closed $2.82 (+6.4%) on Oct 21, 2026
Lexaria Announces Results From Animal Study GLP-1-A26-1
Oct 15, 2026
Closed $2.99 (+6.0%) on Oct 15, 2026
Lexaria Updates Financial Position
Sep 17, 2026
Closed $3.29 (+6.3%) on Sep 17, 2026
Lexaria Bioscience Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Sep 9, 2026
Closed $4.05 (-38.6%) on Sep 10, 2026
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Sep 8, 2026
Closed $9.37 (-33.8%) on Sep 8, 2026
Lexaria to Present at the H.C. Wainwright 28th Annual Global Investment Conference
Sep 4, 2026
Closed $14.15 (+14.9%) on Sep 4, 2026
Lexaria Receives USD$2.6 Million Tax Rebate Payment
Sep 1, 2026
Closed $12.48 (+10.6%) on Sep 1, 2026
Lexaria Bioscience Corp. on 6ix
- News releases
- 34 in the last 12 months · 187 in all · newest Nov 19, 2026 · oldest 2021
- Decks
- 3 decks · latest Dec 31, 2020
Where Lexaria Bioscience Corp. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:LEXX · Home listing · This page | NASDAQ | United States | USD |
| BOATS:LEXX | BOATS | United States | USD |
Valuation
Statements: 4 quarters to May 31, 2026 · price Nov 20, 2026
- Enterprise value
- $4.85M USD
- P/E
- Loss
- EV/sales
- 25.0×
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 1.8×
- Gross margin
- 100.0%
- Operating margin
- Revenue too small
- Net margin
- Revenue too small
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.98
Forecasts
Analysts' consensus from EODHD, read Nov 18, 2026. Not 6ix's view and not investment advice.
- Price target
- 82.50 USD · Analysts' mean
- EPS, year to Aug 2026
- -4.05 · 1 analyst
- Revenue, year to Aug 2026
- 20K · 1 analyst
Team and board
Officers
| Officer | Role |
|---|---|
| Richard Christopher | CEO |
| Michael Shankman | CFO |
| John Docherty | President and Chief Scientific Officer |
| George Jurcic | Head of Investor Relations |
Board
| Director | Role |
|---|---|
| Al Reese | Director |
| Bal Bhullar | |
| Chris Bunka | Director |
| John Docherty | President and Chief Scientific Officer |
| Nicholas Baxter | |
| Richard Christopher | CEO |
| Ted McKechnie | Director |
Events
- Next results
- Nov 25, 2026 (expected)
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Jul 13, 2026 · After close | −1.3% |
| Q2 2026 | Apr 13, 2026 · After close | +4.1% |
| Q1 2026 | Jan 13, 2026 · After close | −3.3% |
| Q4 2025 | Oct 29, 2025 | +3.3% |
| Q3 2025 | Jul 14, 2025 · Before open | −5.3% |
| Q2 2025 | Apr 14, 2025 · After close | +1.4% |
| Q1 2025 | Jan 10, 2025 · After close | −4.6% |
| Q4 2024 | Nov 26, 2024 · After close | −1.9% |
| Q3 2024 | Jul 12, 2024 · After close | +4.3% |
| Q2 2024 | Apr 9, 2024 · After close | −1.5% |
All 20 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q1 2024 | Jan 12, 2024 · After close | +2.6% |
| Q4 2023 | Nov 20, 2023 · After close | +2.4% |
| Q3 2023 | Jul 14, 2023 · After close | −7.5% |
| Q2 2023 | Apr 14, 2023 · After close | −0.5% |
| Q1 2023 | Jan 17, 2023 · After close | 0.0% |
| Q4 2022 | Nov 28, 2022 · Before open | +3.0% |
| Q3 2022 | Jul 14, 2022 · After close | +2.5% |
| Q2 2022 | Apr 11, 2022 · Before open | +6.1% |
| Q1 2022 | Jan 14, 2022 · After close | 0.0% |
| Q4 2021 | Nov 29, 2021 · Before open | +2.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (December 2020) | Investor deck | 30 slides | Dec 31, 2020 |
| Investor Presentation (July 2019) | Investor deck | 27 slides | July 2019 |
| Investor Presentation (November 2017) | Investor deck | 16 slides | Nov 2, 2017 |
Financings
| Raise | Date |
|---|---|
| Common stock on exercise of existing warrants at a reduced price, with new unregistered Series A and Series B warrants Closed: US$5.9M raised · US$12.92 a share · Warrants at US$12.67 · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and general corporate purposes | Sep 9, 2026 |
| Registered direct offering of shares of common stock with concurrent private placement of unregistered warrants Closed: US$3.5M raised · US$1.315 a share · Warrants at US$1.19 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Advance research and development, fund working capital and general corporate purposes | Dec 16, 2025 |
| Registered direct offering of shares of common stock with concurrent private placement of unregistered warrants Closed: US$4M raised · US$1.5 a share · Warrants at US$1.37 for 60 months · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Use of proceeds: Working capital and other general corporate purposes | Sep 29, 2025 |
| Registered direct offering of shares of common stock (or pre-funded warrants) Closed: US$2M raised · US$1 a share · H.C. Wainwright & Co. Dealers: H.C. Wainwright & Co. (lead) Buyers: single institutional investor (2,000,000 shares of common stock) Use of proceeds: Working capital and other general corporate purposes | Apr 28, 2025 |
Open Financings · Read by 6ix AI from the company's releases
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 705.9K | 464.3K | 226.2K | 255.4K | 722.7K | 314.8K | 222.6K | 433.3K | 63.6K | 40.7K |
| Cost of revenue | 2.72K | 4.82K | 31.5K | 71.8K | 175.3K | 99.4K | 22.9K | 25.2K | 29.8K | 45.6K |
| Gross profit | 703.2K | 459.5K | 194.7K | 183.6K | 547.4K | 215.4K | 199.7K | 408.1K | 33.9K | -4.90K |
| Research and development | 8.24M | 2.36M | 3.67M | 1.84M | 1.26M | 387.1K | 555.7K | 492.9K | 54.2K | 9.02K |
| Operating income | -11.9M | -5.75M | -6.53M | -6.62M | -5.69M | -1.28M | ||||
| Depreciation and amortization | 51.2K | 42.4K | 145.4K | 102.7K | 111.7K | 112.8K | 60.5K | 2.31K | 1.49K | 619 |
| EBITDA | -11.8M | -5.71M | -6.39M | -6.52M | -5.58M | -1.28M | ||||
| Interest expense | 6.01K | 2.25K | ||||||||
| Income before tax | -11.9M | -5.81M | -6.71M | -7.38M | -4.17M | -3.99M | -4.16M | -6.61M | -1.93M | -1.27M |
| Income tax | 0 | 6.09K | 2.32K | 17.7K | 0 | 0 | 0 | |||
| Net income | -11.9M | -5.80M | -6.66M | -7.27M | -4.03M | -4.08M | 4.10M | 6.60M | -1.93M | -1.28M |
| Earnings per share, basic | -0.61 | -0.30 | -0.82 | -1.22 | -0.95 | -1.47 | -0.05 | -0.09 | -0.03 | -0.03 |
| Earnings per share, diluted | -0.66 | -0.47 | -1.01 | -0.95 | -1.47 | -0.05 | -0.09 | -0.03 | -0.03 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 1.80M | 6.50M | 1.35M | 5.81M | 10.9M | 1.29M | 1.29M | 1.73M | 2.53M | 93.4K |
| Short-term investments | 143.3K | 55.8K | 125.6K | 347.3K | 833.8K | 19.3K | 64.2K | 10.2K | 0 | |
| Receivables | 368.4K | 154.5K | 126.7K | 201.8K | 342.4K | 313.9K | 273.1K | 265.8K | 45.3K | 131.1K |
| Inventory | 0 | 38.4K | 29.6K | 116.9K | 127.4K | 87.2K | 67.2K | 134.7K | ||
| Current assets | 3.47M | 7.90M | 2.15M | 6.98M | 12.4M | 1.93M | 1.82M | 2.28M | 2.80M | 510.2K |
| Property, plant and equipment | 228.1K | 254.7K | 254.1K | 315.5K | 368.2K | 483.4K | 591.3K | 1.24K | 1.86K | 2.48K |
| Total assets | 4.18M | 8.87M | 3.08M | 7.83M | 13.3M | 2.83M | 2.68M | 2.43M | 2.86M | 566.6K |
| Accounts payable | 35.8K | |||||||||
| Current liabilities | 1.49M | 1.10M | 267.7K | 194.0K | 153.3K | 225.9K | 184.5K | 43.6K | 92.3K | 433.9K |
| Total liabilities | 1.57M | 1.21M | 403.9K | 201.4K | 203.3K | 346.0K | 184.5K | 43.6K | 92.3K | 478.9K |
| Shareholders' equity | 2.99M | 8.04M | 3.04M | 7.95M | 13.1M | 2.48M | 2.49M | 2.39M | 2.77M | 266.0K |
| Shares outstanding | 19.6M | 19.6M | 8.09M | 5.95M | 5.73M | 3.00M | 78.8M | 75.5M | 68.0M | 51.3M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operations | -10.5M | -4.96M | -5.88M | -4.88M | -3.99M | -2.62M | -3.01M | -2.52M | -1.55M | -660.9K |
| Capital spending | -24.6K | -43.0K | -33.7K | -49.2K | 0 | -646.2K | 0 | -3.09K | ||
| Free cash flow | -10.5M | -5.00M | -5.91M | -4.93M | -2.62M | -3.65M | -1.55M | -664.0K | ||
| Cash from investing | -243.0K | -188.6K | -169.6K | -180.6K | 193.9K | -26.8K | -769.2K | -155.4K | -9.70K | -20.1K |
| Cash from financing | 6.05M | 10.3M | 1.59M | -44.6K | 13.4M | 2.65M | 3.33M | 1.87M | 4.00M | 514.3K |
| Change in cash | -4.70M | 5.15M | -4.46M | -5.10M | 9.62M | 8.60K | -442.0K | -806.2K | 2.44M | -166.7K |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| SCHEDULE 13G · Big-stake notice | Nov 16, 2026 | Big-stake notice | SEC |
| EFFECT · Notice that a registration is effective | Oct 14, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Oct 13, 2026 | Offer document | SEC |
| S-3 · Registration statement | Oct 1, 2026 | Offer document | SEC |
| D | Sep 18, 2026 | Other filings | SEC |
| 8-K · Current report | Sep 9, 2026 | Material contract | SEC |
| 8-K · Current report | Sep 1, 2026 | Current report | SEC |
| 8-K · Current report | Aug 17, 2026 | Current report | SEC |
| 8-K · Current report | Aug 10, 2026 | Current report | SEC |
| 8-K · Current report | Jul 30, 2026 | Current report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-Q · Quarterly report | Jul 13, 2026 | Quarterly report | SEC |
| 10-Q · Quarterly report | Apr 13, 2026 | Quarterly report | SEC |
| 4 · Change in ownership | Mar 18, 2026 | Insider trade | SEC |
| 8-K · Current report | Feb 6, 2026 | Current report | SEC |
| 8-K · Current report | Jan 28, 2026 | Meeting outcome | SEC |
| S-8 · Registration statement for employee plans | Jan 28, 2026 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jan 15, 2026 | Other filings | SEC |
| 424B3 · Prospectus | Jan 14, 2026 | Offer document | SEC |
| 25-NSE | Jan 14, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Jan 13, 2026 | Quarterly report | SEC |
| S-3 · Registration statement | Dec 29, 2025 | Offer document | SEC |
| D | Dec 18, 2025 | Other filings | SEC |
| 8-K · Current report | Dec 16, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Dec 16, 2025 | Offer document | SEC |
| DEF 14A · Proxy statement | Dec 10, 2025 | Meeting notice | SEC |
| EFFECT · Notice that a registration is effective | Dec 10, 2025 | Other filings | SEC |
| 424B3 · Prospectus | Dec 9, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 9, 2025 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Dec 5, 2025 | Offer document | SEC |
| S-1/A · Registration statement, amended | Dec 5, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 5, 2025 | Other filings | SEC |
| 10-K · Annual report | Nov 26, 2025 | Annual report | SEC |
| S-1 · Registration statement | Oct 14, 2025 | Offer document | SEC |
| D | Oct 1, 2025 | Other filings | SEC |
| 8-K · Current report | Sep 29, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Sep 29, 2025 | Offer document | SEC |
| 8-K · Current report | Sep 25, 2025 | Current report | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2025 | Insider trade | SEC |
| 10-Q · Quarterly report | Jul 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jun 12, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 16, 2025 | Insider trade | SEC |
| 8-K · Current report | Apr 28, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Apr 25, 2025 | Offer document | SEC |
| 10-Q · Quarterly report | Apr 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Feb 5, 2025 | Material contract | SEC |
| 424B5 · Prospectus | Feb 5, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Jan 31, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 28, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 28, 2025 | Other filings | SEC |
| S-3 · Registration statement | Jan 22, 2025 | Offer document | SEC |
| 3 · Initial statement of ownership | Jan 16, 2025 | Insider trade | SEC |
| 8-K · Current report | Jan 15, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Jan 10, 2025 | Quarterly report | SEC |
| 4 · Change in ownership | Jan 10, 2025 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Jan 6, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 3, 2025 | Management or board change | SEC |
| 8-K · Current report | Dec 18, 2024 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Dec 18, 2024 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Dec 16, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 6, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Dec 5, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 3, 2024 | Other filings | SEC |
| 4 · Change in ownership | Dec 3, 2024 | Insider trade | SEC |
| UPLOAD · Letter from the SEC | Dec 2, 2024 | Other filings | SEC |
| DEF 14A · Proxy statement | Nov 27, 2024 | Meeting notice | SEC |
| S-3 · Registration statement | Nov 26, 2024 | Offer document | SEC |
| 10-K · Annual report | Nov 26, 2024 | Annual report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| PRE 14A · Preliminary proxy statement | Nov 12, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 18, 2024 | Current report | SEC |
| 8-K · Current report | Oct 16, 2024 | Material contract | SEC |
| D | Oct 16, 2024 | Other filings | SEC |
| 424B5 · Prospectus | Oct 16, 2024 | Offer document | SEC |
| 3 · Initial statement of ownership | Oct 2, 2024 | Insider trade | SEC |
| 8-K · Current report | Oct 2, 2024 | Management or board change | SEC |
| SC 13D/A · Big-stake notice, amended | Sep 23, 2024 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Sep 5, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 5, 2024 | Management or board change | SEC |
| 8-K · Current report | Aug 21, 2024 | Material contract | SEC |
| 424B5 · Prospectus | Aug 21, 2024 | Offer document | SEC |
| 4 · Change in ownership | Aug 13, 2024 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Aug 6, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Aug 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Jul 30, 2024 | Insider trade | SEC |
| 8-K · Current report | Jul 17, 2024 | Management or board change | SEC |
| 10-Q · Quarterly report | Jul 12, 2024 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Jun 12, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Jun 11, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jun 7, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jun 7, 2024 | Other filings | SEC |
| S-1 · Registration statement | Jun 3, 2024 | Offer document | SEC |
| 4 · Change in ownership | May 15, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| 4 · Change in ownership | May 10, 2024 | Insider trade | SEC |
| D | May 2, 2024 | Other filings | SEC |
| 8-K · Current report | Apr 30, 2024 | Material contract | SEC |
| SC 13D/A · Big-stake notice, amended | Apr 25, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Apr 24, 2024 | Meeting outcome | SEC |
| 10-Q · Quarterly report | Apr 9, 2024 | Quarterly report | SEC |
| 8-K · Current report | Mar 21, 2024 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Mar 21, 2024 | Other filings | SEC |
| 424B3 · Prospectus | Mar 20, 2024 | Offer document | SEC |
| CORRESP · Letter to the SEC | Mar 18, 2024 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Mar 18, 2024 | Other filings | SEC |
| 3 · Initial statement of ownership | Mar 15, 2024 | Insider trade | SEC |
| 8-K · Current report | Mar 15, 2024 | Management or board change | SEC |
| S-1 · Registration statement | Mar 12, 2024 | Offer document | SEC |
| DEF 14A · Proxy statement | Mar 6, 2024 | Meeting notice | SEC |
| 8-K · Current report | Mar 1, 2024 | Current report | SEC |
| 8-K · Current report | Feb 16, 2024 | Material contract | SEC |
| D | Feb 16, 2024 | Other filings | SEC |
| 424B5 · Prospectus | Feb 16, 2024 | Offer document | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 14, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 30, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Jan 29, 2024 | Other filings | SEC |
| 8-K · Current report | Jan 24, 2024 | Current report | SEC |
| POS AM · Amendment to an effective registration | Jan 24, 2024 | Offer document | SEC |
| S-8 · Registration statement for employee plans | Jan 18, 2024 | Offer document | SEC |
| 10-Q · Quarterly report | Jan 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Jan 4, 2024 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Dec 11, 2023 | Other filings | SEC |
| 424B3 · Prospectus | Dec 8, 2023 | Offer document | SEC |
| CORRESP · Letter to the SEC | Dec 6, 2023 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Dec 6, 2023 | Other filings | SEC |
| S-1 · Registration statement | Nov 30, 2023 | Offer document | SEC |
| 10-K · Annual report | Nov 20, 2023 | Annual report | SEC |
| 8-K · Current report | Nov 3, 2023 | Current report | SEC |
| 4 · Change in ownership | Nov 1, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 30, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Oct 30, 2023 | Insider trade | SEC |
| 8-K · Current report | Oct 18, 2023 | Current report | SEC |
| 8-K · Current report | Oct 16, 2023 | Current report | SEC |
| 8-K · Current report | Oct 12, 2023 | Meeting outcome | SEC |
| D | Oct 4, 2023 | Other filings | SEC |
| 8-K · Current report | Oct 3, 2023 | Material contract | SEC |
| 424B5 · Prospectus | Oct 2, 2023 | Offer document | SEC |
| SC 13D · Big-stake notice | Sep 18, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Aug 28, 2023 | Current report | SEC |
| DEF 14A · Proxy statement | Aug 23, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Aug 9, 2023 | Meeting notice | SEC |
| 8-K · Current report | Jul 28, 2023 | Current report | SEC |
| 4 · Change in ownership | Jul 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jul 25, 2023 | Insider trade | SEC |
| 8-K · Current report | Jul 20, 2023 | Current report | SEC |
| 10-Q · Quarterly report | Jul 14, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jun 23, 2023 | Current report | SEC |
| 8-K · Current report | Jun 12, 2023 | Management or board change | SEC |
| 8-K · Current report | May 12, 2023 | Material contract | SEC |
| 8-K · Current report | May 10, 2023 | Material contract | SEC |
| 424B4 · Prospectus | May 10, 2023 | Offer document | SEC |
| 8-K · Current report | May 10, 2023 | Meeting outcome | SEC |
| EFFECT · Notice that a registration is effective | May 9, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 5, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 5, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 4, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 4, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 3, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 3, 2023 | Other filings | SEC |
| S-1/A · Registration statement, amended | Apr 28, 2023 | Offer document | SEC |
| 10-Q · Quarterly report | Apr 14, 2023 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | Apr 7, 2023 | Other filings | SEC |
| S-1 · Registration statement | Apr 3, 2023 | Offer document | SEC |
| DEF 14A · Proxy statement | Mar 22, 2023 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Mar 10, 2023 | Meeting notice | SEC |
| 8-K · Current report | Mar 3, 2023 | Current report | SEC |
| 4 · Change in ownership | Feb 27, 2023 | Insider trade | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2023 | Big-stake notice | SEC |
| 8-K · Current report | Jan 23, 2023 | Current report | SEC |
| 10-Q/A · Quarterly report, amended | Jan 18, 2023 | Quarterly report | SEC |
| 10-Q · Quarterly report | Jan 17, 2023 | Quarterly report | SEC |
| 8-K · Current report | Jan 17, 2023 | Current report | SEC |
| EFFECT · Notice that a registration is effective | Dec 30, 2022 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Dec 28, 2022 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 23, 2022 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Dec 21, 2022 | Offer document | SEC |
| 10-K/A · Annual report, amended | Dec 6, 2022 | Annual report | SEC |
| 8-K · Current report | Nov 30, 2022 | Current report | SEC |
This page holds 200 of 1,000 filings. Open Filings
Cap table
Built by 6ix from Lexaria Bioscience Corp.’s releases · as of Sep 9, 2026
- Common shares
- 2,106,528
- Fully diluted
- 2,106,528
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 2,106,528 | Sep 9, 2026 |
Warrants and options
| Lot |
|---|
| Warrants · US$12.67 · expiry not stated |
| Warrants · US$1.19 · expire about Dec 2030 |
| Warrants · US$1.37 · expire about Sep 2030 |
Share count over time
| Count | Shares |
|---|---|
| Sep 9, 2026 | 2,106,528 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Albert L Reese Jr Other companies: Atp Oil & Gas Corp (Chief Financial Officer · Nov 16, 2011 – Nov 16, 2011 · Past) | Director · Jan 14, 2021 – May 15, 2025 · Past |
| Allan Horst Spissinger Other companies: Enertopia Corp. (CFO · Aug 18, 2022 – Jan 15, 2025 · Past) | Chief Financial Officer · Jan 9, 2017 – Apr 23, 2020 · Past |
| Baljinder Bhullar Other companies: Enertopia Corp. (CFO, Director · May 20, 2016 – Jan 20, 2017 · Past) | Director · Jan 14, 2025 – May 15, 2025 · Past |
| Brian W Quigley Other companies: Altria Group, Inc. (President & CEO, USSTC · Apr 16, 2012 – Mar 2, 2018 · Past) | Director · Aug 15, 2019 – Apr 23, 2020 · Past |
| Catherine C Turkel Other companies: Eledon Pharmaceuticals, Inc. (President · May 20, 2019 – Mar 19, 2020 · Past) | Director · Sep 2, 2022 – Aug 12, 2024 · Past |
| Christopher Bunka Other companies: Enertopia Corp. (President, Director · Apr 6, 2007 – Dec 17, 2014 · Past) | Director · Since at least Oct 26, 2006 |
| Al Reese | Director · Since at least Nov 4, 2026 |
| Bal Bhullar | Director · Since at least Nov 5, 2026 |
| Chris Bunka | Director · Since at least Jan 30, 2025 |
| David Demartini | Director · Sep 9, 2009 – Jun 18, 2013 · Past |
All 21 people
| Person | Seat |
|---|---|
| George Jurcic | Head of Investor Relations · Since at least Oct 28, 2026 |
| Gregory Downey | Chief Financial Officer · Apr 15, 2021 – Oct 14, 2022 · Past |
| John Docherty | President & CSO, Director · Since at least Oct 26, 2023 |
| Leonard MacMillan | VP - Corp. Development, Director · Jul 14, 2006 – May 26, 2009 · Past |
| Michael Shankman | CFO · Since at least Nov 4, 2026 |
| Nelson Cabatuan | Chief Financial Officer · Mar 14, 2024 – Mar 14, 2024 · Past |
| Nicholas Baxter | Director · Since at least Jul 8, 2011 |
| Richard Christopher | Chief Executive Officer, Director · Since at least May 15, 2025 |
| Ted McKechnie | Director · Since at least Nov 4, 2026 |
| Vanessa Carle | Secretary · Since at least Oct 26, 2023 |
| William Edward McKechnie | Director · Since at least Sep 16, 2015 |
Log in to ask 6ix AI your own questions about Lexaria Bioscience Corp.